Clinical Trials Directory

Trials / Sponsors / Aivita Biomedical, Inc.

Aivita Biomedical, Inc.

Industry · 7 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingAV-GBM-1 vs Control as Adjunctive Therapy Following Surgery and RT/TMZ in Newly Diagnosed GBM
Primary Glioblastoma
Phase 32024-01-01
WithdrawnPhase I-II Trial of Dendritic Cell Vaccine to Prevent COVID-19 in Adults
COVID-19
Phase 1 / Phase 22023-01-01
RecruitingSafety of AV-MEL-1 With Anti-PD-1 Therapy in Metastatic Melanoma
Metastatic Melanoma
Phase 12021-04-21
CompletedPreventive Dendritic Cell Vaccine, AV-COVID-19, in Subjects Not Actively Infected With COVID-19
COVID-19
Phase 22021-04-14
CompletedDendritic Cell Vaccine, AV-COVID-19, to Prevent COVID-19 Infection
COVID-19
Phase 12020-12-07
UnknownAutologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Newly Diagnosed G
Newly Diagnosed Glioblastoma
Phase 22018-06-20
UnknownAutologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Advanced Epitheli
Stage III Ovarian Carcinoma, Stage IV Ovarian Carcinoma, Fallopian Tube Carcinoma
Phase 22017-11-18